Analysis of the Clinical Characteristics of Dipeptidyl Peptidase-4 Inhibitor-Induced Bullous Pemphigoid.
Linli SunChunxia WangCuifang WuYulu ZhouChunjiang WangPublished in: The Annals of pharmacotherapy (2021)
DPP4i drugs are related to the occurrence of BP in diabetic patients, especially elderly men taking vildagliptin.